- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about Dea
Recent news which mentions Dea
Looking for a Rock-Solid Passive Income Stream: Check Out This 5.6%-Yielding Dividend Stock
May 24, 2022
From Motley Fool
From Motley Fool
DEA-Endorsed Cannabis Grower Makes History As First 'Plant-Touching' Firm On NASDAQ, Shares Soared
May 17, 2022
From Benzinga
3 Dividend Stocks You Can Buy and Hold for Decades
May 13, 2022
From Motley Fool
From Benzinga
From Benzinga
Activists Protest At DEA HQ, Demand Legal Access To Psychedelics For Terminally Ill Patients
May 09, 2022
Tickers
DEA
From Benzinga
MMJ BioPharma Cultivation To Produce Quality Cannabis, Meeting DEA's Definition Of Chemical Reproducibility
April 26, 2022
Tickers
DEA
From Benzinga
Easterly Government Props Earnings Conference Call Is Coming Up, Here's What You Need To Know
April 21, 2022
Tickers
DEA
From Benzinga
DEA Under Fire For Blocking Psilocybin As Treatment For Terminally Ill Cancer Patients
April 14, 2022
From Benzinga
DEA Sued By Rhode Island Lab Over 'Foot Dragging' On Marijuana Pharmaceutical Licensing, Here's What We Know For Now
April 13, 2022
From Benzinga
A Recession Could Be Coming: 3 Stocks to Buy to Be Prepared
April 03, 2022
From Motley Fool
3 Brilliant Stocks to Buy in an Uncertain Market
March 25, 2022
From Motley Fool
7 REITs to Buy for March 2022
March 15, 2022
From InvestorPlace
5 of the Safest High-Yield Dividend Stocks on the Planet
March 13, 2022
From Motley Fool
First DEA-Approved Company To Harvest Cannabis For Medical Research Says It Was Worth All The Effort
March 09, 2022
Tickers
DEA
From Benzinga
From Motley Fool
Earnings Scheduled For February 28, 2022
February 28, 2022
From Benzinga
DEA Proposal To Criminalize 5 More Psychedelics: Judge Grants Hearing For Opposition To Make A Case
February 22, 2022
Tickers
DEA
From Benzinga
DEA's Psychedelics Ban To Get Hearing After Advocates Revolt Over Proposed Scheduling
February 18, 2022
Tickers
DEA
From Benzinga
Will The DEA Give In As Advocates Revolt Over Proposed Scheduling Of Five Psychedelic Compounds?
February 07, 2022
Tickers
DEA
From Benzinga
War On Drugs Update: DEA To Expand List Of Banned Psychedelics
February 05, 2022
Tickers
DEA
From Benzinga
Seattle Physician Launches Push To Reschedule Psilocybin For Medical Use
February 04, 2022
Tickers
DEA
From Benzinga
3 Stocks to Buy Now If You're Anxious About the Stock Market
February 02, 2022
From Motley Fool
3 Dividend Stocks to Buy and Hold Forever
January 23, 2022
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.